Citation:Wu Y, Huang ZF, Wang SY, Yang XN, Ou W 2002

Citation

Wu Y, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002 Apr;36(1):1-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11891025.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Wu Y, Huang ZF, Wang SY, Yang XN, Ou W 2002	Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage I NSCLC?	Associate Professor Gavin Wright MD FRACS PhD	completed
Wu Y, Huang ZF, Wang SY, Yang XN, Ou W 2002 2	Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?	Associate Professor Gavin Wright MD FRACS PhD	completed
Wu Y, Huang ZF, Wang SY, Yang XN, Ou W 2002 3	What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?	Associate Professor Gavin Wright MD FRACS PhD	completed

Compare quality appraisals for each clinical question

• [[Clinical question:Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage I NSCLC?|]] (compare critical appraisals)
• [[Clinical question:Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?|]] (compare critical appraisals)

Cited by

1. Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?
2. What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?